BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24265129)

  • 1. Carbimazole/methimazole embryopathy in siblings: a possible genetic susceptibility.
    Goel H; Dudding T
    Birth Defects Res A Clin Mol Teratol; 2013 Nov; 97(11):755-8. PubMed ID: 24265129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal carbimazole and choanal atresia: a new embryopathy.
    Wolf D; Foulds N; Daya H
    Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):1009-11. PubMed ID: 16982979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; Donà M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choanal atresia associated with tracheoesophageal fistula: the spectrum of carbimazole embryopathy.
    Douchement D; Rakza T; Holder M; Bonne NX; Fayoux P
    Pediatrics; 2011 Sep; 128(3):e703-6. PubMed ID: 21807695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbimazole embryopathy-bilateral choanal atresia and patent vitello-intestinal duct: a case report and review of literature.
    Kannan L; Mishra S; Agarwal R; Kartikeyan V; Gupta N; Kabra M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):649-51. PubMed ID: 18671255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
    Bowman P; Osborne NJ; Sturley R; Vaidya B
    QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth defects observed with maternal carbimazole treatment: Six cases reported to Nice's Pharmacovigilance Center.
    Koenig D; Spreux A; Hiéronimus S; Chichmanian RM; Bastiani F; Fénichel P; Brucker-Davis F
    Ann Endocrinol (Paris); 2010 Dec; 71(6):535-42. PubMed ID: 20934171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbimazole embryopathy: an emerging phenotype.
    Foulds N; Walpole I; Elmslie F; Mansour S
    Am J Med Genet A; 2005 Jan; 132A(2):130-5. PubMed ID: 15578620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
    Sachs C; Tebacher-Alt M; Mark M; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2016; 143(6-7):423-35. PubMed ID: 27033749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choanal atresia and hypothelia following methimazole exposure in utero: a second report.
    Wilson LC; Kerr BA; Wilkinson R; Fossard C; Donnai D
    Am J Med Genet; 1998 Jan; 75(2):220-2. PubMed ID: 9450891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grade 1 microtia, wide anterior fontanel and novel type tracheo-esophageal fistula in methimazole embryopathy.
    Gripp KW; Kuryan R; Schnur RE; Kothawala M; Davey LR; Antunes MJ; Reichard KW; Schneider A; Hall BD
    Am J Med Genet A; 2011 Mar; 155A(3):526-33. PubMed ID: 21344626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choanal atresia - a recurrent feature of foetal carbimazole syndrome.
    Myers AK; Reardon W
    Clin Otolaryngol; 2005 Aug; 30(4):375-7. PubMed ID: 16209687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbimazole embryopathy in a Chinese population: case series and literature review.
    Ting YH; Zhou Y; Lao TT
    Birth Defects Res A Clin Mol Teratol; 2013 Apr; 97(4):225-9. PubMed ID: 23457082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new possible phenotype of carbimazole embryopathy: A case report].
    Mellerio H; Gay CL; Forest MG; Orgiazzi J; Nicolino M
    Arch Pediatr; 2010 May; 17(5):511-6. PubMed ID: 20395117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methimazole embryopathy: delineation of the phenotype.
    Clementi M; Di Gianantonio E; Pelo E; Mammi I; Basile RT; Tenconi R
    Am J Med Genet; 1999 Mar; 83(1):43-6. PubMed ID: 10076883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methimazole embryopathy: a contribution to defining the phenotype.
    Valdez RM; Barbero PM; Liascovich RC; De Rosa LF; Aguirre MA; Alba LG
    Reprod Toxicol; 2007 Feb; 23(2):253-5. PubMed ID: 17218082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions.
    Chang LC; Chang CC; Chen PL; Wang SH; Chen YH; Tsai YH; Shih SR; Chiu WY; Fann CS; Yang WS; Chang TC
    Expert Opin Drug Saf; 2018 Aug; 17(8):775-784. PubMed ID: 30067105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole?
    Barwell J; Fox GF; Round J; Berg J
    Am J Med Genet; 2002 Jul; 111(1):55-6; discussion 54. PubMed ID: 12124735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.